Anika starts new clinical trials for Orthovisc
This article was originally published in Clinica
Executive Summary
Anika Therapeutics has filed an investigational device exemption with the FDA for permission to begin a further clinical trial of its treatment for osteoarthritic knees. The company failed to win US marketing approval for the product last year due to insufficient data from Anika's initial study.